ZTS

Zoetis Inc. · Healthcare · Drug Manufacturers - General
$73.96
+0.99 (+1.36%)
Mkt Cap: 31.01B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.1%
Dividend YieldN/A
Market Cap31.01B
Volume3.26M
Recent News
Zoetis: A Solid Long-Term Buy After Harsh Drawdown
seekingalpha.com · 2026-08-18
Zoetis: Another Bad Quarter, Some Value Trap Risk But Shares Still Cheap
seekingalpha.com · 2026-08-16
Zoetis: The Growth Story Has Broken, But The Valuation Finally Makes Sense
seekingalpha.com · 2026-08-14
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
businesswire.com · 2026-08-13
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
reuters.com · 2026-08-13
Zoetis Q2 Earnings Call Highlights
defenseworld.net · 2026-08-11

Unlock the Full Deep Scan

9 AI agents analyze ZTS across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →